These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9123263)

  • 1. Recipient-donor microchimerism is not a prerequisite for the maintenance of allograft tolerance.
    Shirwan H; Wang C; Barwari L; Cramer DV
    Transplant Proc; 1997; 29(1-2):1182-3. PubMed ID: 9123263
    [No Abstract]   [Full Text] [Related]  

  • 2. Pretransplant injection of allograft recipients with donor blood or lymphocytes permits allograft tolerance without the presence of persistent donor microchimerism.
    Shirwan H; Wang HK; Barwari L; Makowka L; Cramer DV
    Transplantation; 1996 May; 61(9):1382-6. PubMed ID: 8629301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathymic injection of donor alloantigens induces specific tolerance to cardiac allografts.
    Goss JA; Nakafusa Y; Yu S; Flye MW
    Transplantation; 1993 Jul; 56(1):166-73. PubMed ID: 8333039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microchimerism and allograft acceptance: is it caused by microchimerism or graft antigens?
    Kimura H; Hua Y; Goto T; Kokubo T; Amemiya H; Suzuki S; Miyamoto M; Tanaka K
    Transplant Proc; 2000 Nov; 32(7):2045-6. PubMed ID: 11120059
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of microchimerism on long-term graft survival after donor-specific transfusion in a rat heart transplantation model.
    Ito H; Hamano K; Gohra H; Katoh T; Fujimura Y; Zempo N; Esato K
    Transplant Proc; 1998 Nov; 30(7):3862-4. PubMed ID: 9838690
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of a limited T-cell receptor V beta repertoire in alloantigen recognition and allograft rejection.
    Shirwan H; Barwari L; Wang C; Cramer DV
    Transplant Proc; 1997; 29(1-2):1050-1. PubMed ID: 9123192
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of the T-cell receptor V beta repertoire in rejecting rat cardiac allografts using a quantitative polymerase chain reaction.
    Shirwan H; Makowka L; Cramer DV
    Transplant Proc; 1993 Oct; 25(5):2780-1. PubMed ID: 8212233
    [No Abstract]   [Full Text] [Related]  

  • 9. Donor-specific tolerance to cardiac, but not renal, allografts is induced by intrathymic transfer of donor splenocytes.
    Nakafusa Y; Goss JA; Flye MW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):292-4. PubMed ID: 8438305
    [No Abstract]   [Full Text] [Related]  

  • 10. Microchimerism and graft acceptance: IV. Cardiac allograft acceptance following anti-adhesion molecule antibody therapy.
    Suzuki H; Hara MH; Miyahara T; Tanigawa M; Matsuzaki Y; Onitsuka T; Shibata K; Koga Y; Yamashita A; Miyamoto M; Suzuki S; Amemiya H; Iwaya M; Miyasaka M; Kimura H
    Transplant Proc; 1996 Aug; 28(4):2058-60. PubMed ID: 8769155
    [No Abstract]   [Full Text] [Related]  

  • 11. Intrathymic microchimerism predicts rejection response in allograft recipients.
    Ota H; Gotoh M; Ohzato H; Dono K; Takeda Y; Umeshita K; Sakon M; Nishisho I; Monden M
    Transplant Proc; 1997; 29(1-2):1214. PubMed ID: 9123279
    [No Abstract]   [Full Text] [Related]  

  • 12. Microchimerism and graft acceptance: cardiac allograft acceptance following antiadhesion molecules antibody therapy.
    Hara MH; Tanigawa M; Matsuzaki M; Onitsuka T; Shibata K; Koga Y; Suzuki H; Yamashita A; Miyamoto M; Li XK; Suzuki S; Amemiya H; Yokoi Y; Iwaya M; Yamaguchi A; Masaki Y; Miyasaka M; Kimura H
    Transplant Proc; 1996 Jun; 28(3):1370-1. PubMed ID: 8658699
    [No Abstract]   [Full Text] [Related]  

  • 13. Different response of intestinal and cardiac allografts to pretreatment with UV-B irradiated donor-specific leukocytes (DL) or DL alone.
    Gundlach M; Oluwole SF; Pohland CC; Broelsch CE; Hardy MA
    Transplant Proc; 1996 Oct; 28(5):2482-3. PubMed ID: 8907913
    [No Abstract]   [Full Text] [Related]  

  • 14. MHC class II presenting cells are necessary for the induction of intrathymic tolerance.
    Goss JA; Nakafusa Y; Flye MW
    Ann Surg; 1993 May; 217(5):492-9; discussion 499-501. PubMed ID: 8489312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of passenger leukocytes to the induction and maintenance of heart allograft acceptance.
    Ko S; Deiwick A; Dinkel A; Wonigeit K; Schlitt HJ
    Transplant Proc; 1999; 31(1-2):158-9. PubMed ID: 10083056
    [No Abstract]   [Full Text] [Related]  

  • 16. Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: analysis of the immune status.
    Yamaguchi Y; Mori K; Bollinger RR
    J Clin Lab Immunol; 1990 Jun; 32(2):59-66. PubMed ID: 1967040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance to a second donor-matched allograft following local immune modulation using transfer of sequences encoding CTLA4Ig.
    Shaked A; Olthoff K; Sellers M; Chen XD; Gelman A
    Transplant Proc; 1997; 29(1-2):1026. PubMed ID: 9123180
    [No Abstract]   [Full Text] [Related]  

  • 18. Portal vein administration of donor cells promotes peripheral allospecific hyporesponsiveness and graft tolerance.
    Yu S; Nakafusa Y; Flye MW
    Surgery; 1994 Aug; 116(2):229-34; discussion 234-5. PubMed ID: 8047989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microchimerism and heart allograft acceptance.
    Masaki Y; Hirasawa A; Okuyama S; Tsujimoto G; Iwaya M; Li XK; Yokoi Y; Nakamura S; Baba S; Miyamoto M
    Transplant Proc; 1995 Feb; 27(1):148-50. PubMed ID: 7878949
    [No Abstract]   [Full Text] [Related]  

  • 20. Brequinar sodium suppresses liver allograft rejection and induces permanent tolerance in the rat.
    Knoop M; Cramer DV; Chapman FC; Makowka L
    Transplant Proc; 1993 Feb; 25(1 Pt 1):706-7. PubMed ID: 8438447
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.